# Mechanisms of Smell Improvement With Dupilumab.

> **NCT05964465** · PHASE4 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 60 (actual)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps

## Interventions

- **DRUG:** Dupilumab

## Key facts

- **NCT ID:** NCT05964465
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-10
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-01-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05964465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05964465, "Mechanisms of Smell Improvement With Dupilumab.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05964465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*